{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T21:56:57Z","timestamp":1781474217136,"version":"3.54.1"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T00:00:00Z","timestamp":1642636800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>The present study had four aims. First, neuronal injury markers, including neurofilament light (NF-L), total tau, glial fibrillary acidic protein (GFAP) and ubiquitin C-terminal hydrolase (UCH-L1), were compared between individuals with and without adult-onset myotonic dystrophy type 1 (DM1). Second, the impact of age and CTG repeat on brain injury markers was evaluated. Third, change in brain injury markers across the study period was quantified. Fourth, associations between brain injury markers and cerebral white matter (WM) fractional anisotropy (FA) were identified.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Yearly assessments, encompassing blood draws and diffusion tensor imaging on a 3T scanner, were conducted on three occasions. Neuronal injury markers were quantified using single molecule array (Simoa).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The sample included 53 patients and 70 controls. NF-L was higher in DM1 patients than controls, with individuals in the premanifest phases of DM1 (PreDM1) exhibiting intermediate levels (<jats:inline-formula><mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M1\"><mml:msubsup><mml:mrow><mml:mi>\u03c7<\/mml:mi><\/mml:mrow><mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(<\/mml:mo><mml:mrow><mml:mn>2<\/mml:mn><\/mml:mrow><mml:mo stretchy=\"false\">)<\/mml:mo><\/mml:mrow><\/mml:mrow><mml:mrow><mml:mn>2<\/mml:mn><\/mml:mrow><\/mml:msubsup><mml:mo>=<\/mml:mo><\/mml:math><\/jats:inline-formula>38.142, <jats:italic>P<\/jats:italic> &amp;lt; 0.001). Total tau was lower in DM1 patients than controls (Estimate = \u22120.62, 95% confidence interval [CI] \u22120.95: \u22120.28, <jats:italic>P<\/jats:italic> &amp;lt; 0.001), while GFAP was elevated in PreDM1 only (Estimate = 30.37, 95% CI 10.56:50.19, <jats:italic>P<\/jats:italic> = 0.003). Plasma concentrations of UCH-L1 did not differ between groups. The age by CTG interaction predicted NF-L: patients with higher estimated progenitor allelege length (ePAL) had higher NF-L at a younger age, relative to patients with lower CTG repeat; however, the latter exhibited faster age-related change (Estimate = \u22120.0021, 95% CI \u22120.0042: \u22120.0001, <jats:italic>P<\/jats:italic> = 0.045). None of the markers changed substantially over the study period. Finally, cerebral WM FA was significantly associated with NF-L (Estimate = \u221242.86, 95% CI \u221282.70: \u22123.02, <jats:italic>P<\/jats:italic> = 0.035).<\/jats:p><\/jats:sec><jats:sec><jats:title>Interpretation<\/jats:title><jats:p>While NF-L appears sensitive to disease onset and severity, its utility as a marker of progression remains to be determined. The tau assay may have low sensitivity to tau pathology associated with DM1.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2021.791065","type":"journal-article","created":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T04:39:59Z","timestamp":1642653599000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Blood-Based Markers of Neuronal Injury in Adult-Onset Myotonic Dystrophy Type 1"],"prefix":"10.3389","volume":"12","author":[{"given":"Ellen","family":"van der Plas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey D.","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy R.","family":"Koscik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Magnotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren G.","family":"Monckton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah A.","family":"Cumming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy C.","family":"Gottschalk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Hefti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie","family":"Gutmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peggy C.","family":"Nopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,1,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1093\/arclin\/acx008","article-title":"Brain involvement in myotonic dystrophy type 1: a morphometric and diffusion tensor imaging study with neuropsychological correlation","volume":"32","author":"Cabada","year":"2017","journal-title":"Arch Clin Neuropsychol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e104697","DOI":"10.1371\/journal.pone.0104697","article-title":"Cognitive impairment in myotonic dystrophy type 1 is associated with white matter damage","volume":"9","author":"Caso","year":"2014","journal-title":"PLoS ONE."},{"key":"B3","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1080\/02841850510015974","article-title":"Diffusion tensor imaging of cerebral white matter in patients with myotonic dystrophy","volume":"46","author":"Fukuda","year":"2005","journal-title":"Acta Radiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"3530","DOI":"10.1093\/brain\/awr299","article-title":"The brain in myotonic dystrophy 1 and 2: evidence for a predominant white matter disease","volume":"134","author":"Minnerop","year":"2011","journal-title":"Brain."},{"key":"B5","doi-asserted-by":"publisher","first-page":"101615","DOI":"10.1016\/j.nicl.2018.101615","article-title":"Structural white matter networks in myotonic dystrophy type 1","volume":"21","author":"van Dorst","year":"2019","journal-title":"Neuroimage Clin."},{"key":"B6","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jns.2014.04.005","article-title":"Tractography reveals diffuse white matter abnormalities in Myotonic Dystrophy Type 1","volume":"341","author":"Wozniak","year":"2014","journal-title":"J Neurol Sci."},{"key":"B7","doi-asserted-by":"publisher","first-page":"807","DOI":"10.3349\/ymj.2017.58.4.807","article-title":"Cortical thickness and white matter integrity are associated with CTG expansion size in myotonic dystrophy type I","volume":"58","author":"Yoo","year":"2017","journal-title":"Yonsei Med J."},{"key":"B8","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.nicl.2016.04.012","article-title":"Relationship of white and gray matter abnormalities to clinical and genetic features in myotonic dystrophy type 1","volume":"11","author":"Zanigni","year":"2016","journal-title":"Neuroimage Clin."},{"key":"B9","doi-asserted-by":"publisher","first-page":"4886","DOI":"10.1038\/s41598-021-84520-2","article-title":"White matter microstructure relates to motor outcomes in myotonic dystrophy type 1 independently of disease duration and genetic burden","volume":"11","author":"Koscik","year":"2021","journal-title":"Sci Rep."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e577","DOI":"10.1212\/NXG.0000000000000577","article-title":"Neurocognitive features of motor premanifest individuals with myotonic dystrophy type 1","volume":"7","author":"van der Plas","year":"2021","journal-title":"Neurology Genetics."},{"key":"B11","doi-asserted-by":"publisher","first-page":"700796","DOI":"10.3389\/fneur.2021.700796","article-title":"Cognitive deficits, apathy, and hypersomnolence represent the core brain symptoms of adult-onset myotonic dystrophy type 1","volume":"12","author":"Miller","year":"2021","journal-title":"Front Neurol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1002\/acn3.51234","article-title":"Blood neurofilament light: a critical review of its application to neurologic disease","volume":"7","author":"Barro","year":"2020","journal-title":"Ann Clin Transl Neurol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.parkreldis.2021.04.017","article-title":"Plasma neurofilament light in Huntington's disease: a marker for disease onset, but not symptom progression","volume":"87","author":"Parkin","year":"2021","journal-title":"Parkinsonism Relat Disord."},{"key":"B14","doi-asserted-by":"publisher","first-page":"105311","DOI":"10.1016\/j.nbd.2021.105311","article-title":"Plasma neurofilament light chain predicts cerebellar atrophy and clinical progression in spinocerebellar ataxia","volume":"153","author":"Coarelli","year":"2021","journal-title":"Neurobiol Dis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/S1474-4422(17)30124-2","article-title":"Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis","volume":"16","author":"Byrne","year":"2017","journal-title":"Lancet Neurol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/ene.12237","article-title":"Cerebrospinal fluid biomarkers of neurodegeneration in patients with juvenile and classic myotonic dystrophy type 1","volume":"21","author":"Peric","year":"2014","journal-title":"Eur J Neurol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1111\/j.1468-1331.2008.02217.x","article-title":"Cerebrospinal fluid tau and amyloid beta42 protein in patients with myotonic dystrophy type 1","volume":"15","author":"Winblad","year":"2008","journal-title":"Eur J Neurol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.pneurobio.2011.01.005","article-title":"GFAP in health and disease","volume":"93","author":"Middeldorp","year":"2011","journal-title":"Prog Neurobiol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/02699052.2017.1382717","article-title":"The diagnostic values of UCH-L1 in traumatic brain injury: a meta-analysis","volume":"32","author":"Shahjouei","year":"2018","journal-title":"Brain Inj."},{"key":"B20","volume-title":"Kit Instructions for HD-1\/HD-X","author":"Simoa","year":"2017"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/hmg\/4.1.1","article-title":"Somatic mosaicism, germline expansions, germline reversions and intergenerational reductions in myotonic dystrophy males: small pool PCR analyses","volume":"4","author":"Monckton","year":"1995","journal-title":"Hum Mol Genet."},{"key":"B22","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1385\/1-59259-804-8:061","article-title":"Analysis of unstable triplet repeats using small-pool polymerase chain reaction","volume":"277","author":"Gomes-Pereira","year":"2004","journal-title":"Methods Mol Biol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"3558","DOI":"10.1093\/hmg\/dds185","article-title":"Somatic instability of the expanded CTG triplet repeat in myotonic dystrophy type 1 is a heritable quantitative trait and modifier of disease severity","volume":"21","author":"Morales","year":"2012","journal-title":"Hum Mol Genet."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e995","DOI":"10.1212\/WNL.0000000000008056","article-title":"Genetic determinants of disease severity in the myotonic dystrophy type 1 OPTIMISTIC cohort","volume":"93","author":"Cumming","year":"2019","journal-title":"Neurology."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/protex.2018.089","article-title":"Library preparation and MiSeq sequencing for the genotyping-by-sequencing of the Huntington disease HTT exon one trinucleotide repeat and the quantification of somatic mosaicism","author":"Ciosi","year":"2018","journal-title":"Protocol Exchange."},{"key":"B26","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.neuroimage.2017.08.047","article-title":"Harmonization of multi-site diffusion tensor imaging data","volume":"161","author":"Fortin","year":"2017","journal-title":"Neuroimage."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1093\/brain\/awaa098","article-title":"Neurofilaments: neurobiological foundations for biomarker applications","volume":"143","author":"Gafson","year":"2020","journal-title":"Brain."},{"key":"B28","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/978-3-319-57193-5_16","article-title":"Cell Death Mechanisms of Neurodegeneration","volume":"15","author":"Fan","year":"2017","journal-title":"Adv Neurobiol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3389\/fncel.2017.00101","article-title":"Myotonic dystrophies: state of the art of new therapeutic developments for the CNS","volume":"11","author":"Gourdon","year":"2017","journal-title":"Front Cell Neurosci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"e0213381","DOI":"10.1371\/journal.pone.0213381","article-title":"Tracking the brain in myotonic dystrophies: A 5-year longitudinal follow-up study","volume":"14","author":"Gliem","year":"2019","journal-title":"PLoS ONE."},{"key":"B31","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3389\/fnmol.2013.00057","article-title":"Brain pathology in myotonic dystrophy: when tauopathy meets spliceopathy and RNAopathy","volume":"6","author":"Caillet-Boudin","year":"2014","journal-title":"Front Mol Neurosci."},{"key":"B32","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1093\/hmg\/10.19.2143","article-title":"Dysregulation of human brain microtubule-associated tau mRNA maturation in myotonic dystrophy type 1","volume":"10","author":"Sergeant","year":"2001","journal-title":"Hum Mol Genet."},{"key":"B33","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1212\/WNL.47.3.711","article-title":"Specific tau variants in the brains of patients with myotonic dystrophy","volume":"47","author":"Vermersch","year":"1996","journal-title":"Neurology."},{"key":"B34","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/neup.12721","article-title":"Human brain pathology in myotonic dystrophy type 1: a systematic review","volume":"41","author":"Weijs","year":"2021","journal-title":"Neuropathology."},{"key":"B35","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.neulet.2014.01.055","article-title":"Role of GFAP in CNS injuries","volume":"565","author":"Brenner","year":"2014","journal-title":"Neurosci Lett."},{"key":"B36","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1177\/1073858418809941","article-title":"Astrocytes: heterogeneous and dynamic phenotypes in neurodegeneration and innate immunity","volume":"25","author":"Cunningham","year":"2019","journal-title":"Neuroscientist."},{"key":"B37","doi-asserted-by":"publisher","first-page":"108634","DOI":"10.1016\/j.celrep.2020.108634","article-title":"Transcriptome alterations in myotonic dystrophy frontal cortex","volume":"34","author":"Otero","year":"2021","journal-title":"Cell Rep."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.791065\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T04:40:04Z","timestamp":1642653604000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.791065\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,20]]},"references-count":37,"alternative-id":["10.3389\/fneur.2021.791065"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2021.791065","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,20]]},"article-number":"791065"}}